PAR 1.69% 29.0¢ paradigm biopharmaceuticals limited..

PATENT REJECTED BUT PAR SILENT, page-13

  1. 314 Posts.
    lightbulb Created with Sketch. 37
    This is an interesting article on drug repurposing but your heading is misleading
    I can't see any mention of PAR at all but worth a read
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.